ReviewMolecular biology reports2022

Risks of mucormycosis in the current Covid-19 pandemic: a clinical challenge in both immunocompromised and immunocompetent patients.

P Monika et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.